What they were paid
Supernus Pharmaceuticals Director Compensation Table · all 4 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $85,000 | $150,002 | $150,011 | $0 | $385,013 |
| FY2024 | $85,000 | $150,010 | $142,678 | — | $377,688 |
| FY2022 | $85,000 | $125,000 | $130,543 | — | $340,544 |
| FY2021 | $85,000 | $125,013 | $125,197 | — | $335,210 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Supernus Pharmaceuticals, Inc. DEF 14A filed April 30, 2026, accession 0001104659-26-053111, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Supernus Pharmaceuticals, Inc. filed document, accession 0001104659-26-053111. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.
Get the Supernus Pharmaceuticals Board Governance Report
$385,013 Frederick M. Hudson, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 30, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025Supernus Pharmaceuticals pays directors a $50,000 cash retainer and $150,000 in RSUs/Options.
Committees
FY2025 · as the proxy prints themAudit (Chair) · Compensation
The rest of the Supernus Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Barbara Ryan | Independent Director | $220,466 |
| Bethany L. Sensenig | Independent Director | $362,513 |
| Carrolee Barlow | Independent Director | $376,013 |
| Charles W. Newhall III | Chair of the Board | $417,013 |
| Daniel Ninivaggi | Independent Director | $186,697 |
| David Wheadon | Chair of the Board | $441,027 |
| Georges Gemayel | Independent Director | $398,513 |
| Jack A. Khattar | Director | — |
| Jo LeCouilliard | Independent Director | $42,035 |
| Juliet Thompson | Independent Director | $251,563 |
| Keith Humphreys | Independent Director | $196,785 |
| Mark Stejbach | Independent Director | $217,511 |
| Peter Bains | Independent Director | $39,920 |
| Tony Kingsley | Independent Director | $140,000 |
The full Supernus Pharmaceuticals compensation record
free company briefThis page is one director within Supernus Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the Supernus Pharmaceuticals proxy · each links to its own free briefOrder SUPN
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.